Travis S CreveCoeur, Alexander T Yahanda, Cormac O Maher, Gabrielle W Johnson, Laurie L Ackerman, P David Adelson, Raheel Ahmed, Gregory W Albert, Phillipp R Aldana, Tord D Alden, Richard C E Anderson, Lissa Baird, David F Bauer, Karin S Bierbrauer, Douglas L Brockmeyer, Joshua J Chern, Daniel E Couture, David J Daniels, Robert C Dauser, Susan R Durham, Richard G Ellenbogen, Ramin Eskandari, Herbert E Fuchs, Timothy M George, Gerald A Grant, Patrick C Graupman, Stephanie Greene, Jeffrey P Greenfield, Naina L Gross, Daniel J Guillaume, Gabe Haller, Todd C Hankinson, Gregory G Heuer, Mark Iantosca, Bermans J Iskandar, Eric M Jackson, Andrew H Jea, James M Johnston, Robert F Keating, Michael P Kelly, Nickalus Khan, Mark D Krieger, Jeffrey R Leonard, Francesco T Mangano, Timothy B Mapstone, J Gordon McComb, Arnold H Menezes, Michael Muhlbauer, W Jerry Oakes, Greg Olavarria, Brent R O'Neill, Tae Sung Park, John Ragheb, Nathan R Selden, Manish N Shah, Chevis Shannon, Joshua S Shimony, Jodi Smith, Matthew D Smyth, Scellig S D Stone, Jennifer M Strahle, Mandeep S Tamber, James C Torner, Gerald F Tuite, Scott D Wait, John C Wellons, William E Whitehead, David D Limbrick
BACKGROUND: Occipital-cervical fusion (OCF) and ventral decompression (VD) may be used in the treatment of pediatric Chiari-1 malformation (CM-1) with syringomyelia (SM) as adjuncts to posterior fossa decompression (PFD) for complex craniovertebral junction pathology. OBJECTIVE: To examine factors influencing the use of OCF and OCF/VD in a multicenter cohort of pediatric CM-1 and SM subjects treated with PFD. METHODS: The Park-Reeves Syringomyelia Research Consortium registry was used to examine 637 subjects with cerebellar tonsillar ectopia ≥ 5 mm, syrinx diameter ≥ 3 mm, and at least 1 yr of follow-up after their index PFD...
January 13, 2021: Neurosurgery